Thor Medical ASA 8NN.F Stock
Thor Medical ASA Price Chart
Thor Medical ASA 8NN.F Financial and Trading Overview
| Thor Medical ASA stock price | 0.09 EUR |
| Previous Close | 0.18 EUR |
| Open | 0.22 EUR |
| Bid | 0.23 EUR x 400000 |
| Ask | 0.24 EUR x 400000 |
| Day's Range | 0.22 - 0.22 EUR |
| 52 Week Range | 0.05 - 0.71 EUR |
| Volume | 9.4K EUR |
| Avg. Volume | 333 EUR |
| Market Cap | 25.47M EUR |
| Beta (5Y Monthly) | 1.613409 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
8NN.F Valuation Measures
| Enterprise Value | -77806440 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.39909092 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.254 |
Trading Information
Thor Medical ASA Stock Price History
| Beta (5Y Monthly) | 1.613409 |
| 52-Week Change | -68.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.71 EUR |
| 52 Week Low | 0.05 EUR |
| 50-Day Moving Average | 0.07 EUR |
| 200-Day Moving Average | 0.09 EUR |
8NN.F Share Statistics
| Avg. Volume (3 month) | 333 EUR |
| Avg. Daily Volume (10-Days) | 1.83K EUR |
| Shares Outstanding | 116.04M |
| Float | 95.3M |
| Short Ratio | N/A |
| % Held by Insiders | 51.09% |
| % Held by Institutions | 8.36% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -97.63% |
| Return on Equity (ttm) | -304.60% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -306159008 EUR |
| Net Income Avi to Common (ttm) | -311240992 EUR |
| Diluted EPS (ttm) | -0.24 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 98.72M EUR |
| Total Cash Per Share (mrq) | 0.85 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.464 |
| Book Value Per Share (mrq) | 0.55 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -409079008 EUR |
| Levered Free Cash Flow (ttm) | -295513504 EUR |
Profile of Thor Medical ASA
| Country | Germany |
| State | N/A |
| City | Oslo |
| Address | KjelsAsveien 168 B |
| ZIP | 0884 |
| Phone | 47 22 18 33 01 |
| Website | https://www.nordicnanovector.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 18 |
Nordic Nanovector ASA, a biopharmaceutical company, develops therapeutics for hematological cancers in Norway. The company's lead product candidate is Betalutin, a CD37-targeting radioimmunotherapy for the treatment of patients with non-hodgkin lymphoma. Its preclinical development products include Humalutin for treatment of non-Hodgkin's lymphoma; Alpha37, a CD37-targeting radioimmunotherapy for treating chronic lymphatic leukemia; and Multiple fully humanized anti-CD37 antibodies for treatment of haematological cancers and autoimmune diseases. The company is also developing 89Zr-NNV003, a CD37-targeting companion PET diagnostic for detection and dosimetry of CD37 expressing tumors. The company has collaboration agreements with Orano Med; Paul Scherrer Institute; ArevaMed; LegoChem Bio; and Heidelberg Pharma. It also has a research collaboration with the University of Pennsylvania development of a CD37-targeting CAR-T in haematological cancers. The company was formerly known as Nordic Nanovector AS and changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was incorporated in 2009 and is headquartered in Oslo, Norway.
Q&A For Thor Medical ASA Stock
What is a current 8NN.F stock price?
Thor Medical ASA 8NN.F stock price today per share is 0.09 EUR.
How to purchase Thor Medical ASA stock?
You can buy 8NN.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Thor Medical ASA?
The stock symbol or ticker of Thor Medical ASA is 8NN.F.
Which industry does the Thor Medical ASA company belong to?
The Thor Medical ASA industry is Biotechnology.
How many shares does Thor Medical ASA have in circulation?
The max supply of Thor Medical ASA shares is 233.54M.
What is Thor Medical ASA Price to Earnings Ratio (PE Ratio)?
Thor Medical ASA PE Ratio is now.
What was Thor Medical ASA earnings per share over the trailing 12 months (TTM)?
Thor Medical ASA EPS is 0 EUR over the trailing 12 months.
Which sector does the Thor Medical ASA company belong to?
The Thor Medical ASA sector is Healthcare.